The Complementary Contributions of Sensory Stimulation and Social Support During Snoezelen Room Therapy on the General Physical and Emotional Health of the Elderly Population: Optimization of the Nursing Home Resources.

Over time, lifespan is extending, the population is aging, and accordingly there is a great demand for hospital beds in nursing homes, increasing attention to this population and the services they receive. Mostly, elderly population living in nursing homes suffers from dementia, Alzheimer, depression, agitation, and other diseases that require multidisciplinary treatment.

In addition to the medical and pharmacological treatments that patients receive to maintain functional medical status, there is a great need for non-pharmacological treatments, that may improve quality of life, mental well-being, and life satisfaction.

There are several treatment approaches of multisensory stimulation environment (MSSE). MSSE in the Snoezelen room therapy recognized as benefiting the patients' physical, mental, and emotional health status. In addition, there is great importance of intervention by social interaction, support, and encouragement.

However, the effect of combined intervention of MSSE in Snoezelen room therapy and social support, has not yet been sufficiently studied in elderly patients in nursing homes. These two interventions - together - are supposed to have an increased effect on physical and mental wellbeing of elderly.

Study Overview

• Status: Recruiting
• Conditions: Aging; Loneliness
• Intervention / Treatment: Other: sensory stimulating therapy; Other: social support

• Study Type: Interventional
• Enrollment (Anticipated): 100
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Pavel Goldstein, PhD; Phone Number: 0542488445; Email: pavelg@stat.haifa.ac.il
• Study Contact Backup: Name: Sewar R Khatib, MHA; Email: sewar94@outlook.com

Study Locations

• Israel
  • North
    • Haifa, North, Israel, 2020000
      • Recruiting
      • Ahuzat Moriah Shfraam
      • Contact: sewar r khatib, MHA student; Phone Number: AM 0509967091; Email: sewar94@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 65 years and older (OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patients living in the Ahuzat Moriah nursing home\ geriatric nursing hospital in Shefar'am.

Exclusion Criteria:

• Patients with epilepsy and aggressive patients. *We do not limit the participation of patients whose cognitive level is very low.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: SUPPORTIVE_CARE
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: SINGLE

Number of Arms

3

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
ACTIVE_COMPARATOR: sensory-stimulating therapy	Other: sensory stimulating therapy; therapy session in the snoozlen room accompanied by social support.; Other Names: integrative approach sensory stimulating therapy and social support
ACTIVE_COMPARATOR: social interaction	Other: social support; ten minutes of conversing.
EXPERIMENTAL: combined sensory-stimulating therapy and social interaction.	Other: sensory stimulating therapy; therapy session in the snoozlen room accompanied by social support.; Other Names: integrative approach sensory stimulating therapy and social support; Other: social support; ten minutes of conversing.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
pain, patient- reported outcome, measured by a ruler from zero to 10, on the Likert scale	An interval variable measured by a ruler from zero to 10, on the Likert scale, and with the help of illustrations of faces, the farther away from zero, the higher the intensity of pain.	four weeks
grip strength	A continuous quantitative variable presented in numerical values of isometric grip force from 0 to 90 kg and will be measured by Jamar hydraulic dynamometer. The hand grip strength will be measured in a hydraulic dynamometer borrowed from the university. The assessment does not involve any potential damage, a two-minute test in which the subject is required to press a device to measure grip strength.	eighteen minutes
life satisfaction, patient-reported outcome.	using the SWLS questionnaire before the first session and after the fourth(last) session as an estimation tool .Interval variable, showing scores ranging from 5-35, on the Likert scale, the higher the score it indicates more life satisfaction.	four weeks
general anxiety disorder, patient- reported outcome	using the GAD questionnaire before the first session and after the fourth(last) session as an estimation tool.GAD- is an interval variable, which will be measured using the sum of the reports on the 7 statements on the Likert scale from 0 to 3, the higher the score on this questionnaire, the higher the level of anxiety among the patient. The total score range is from 0-21.	four weeks
blood pressure	Continuous quantitative variable, will be measured by a blood pressure monitor "Welch Allyn" measuring instrument\ device and quantitatively represented, this result variable will examine the quantitative change in systolic and diastolic blood pressure.	eighteen minutes

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
pulse(heart rate index)	Continuous quantitative variable, will be measured by "Welch Allyn" measuring instrument\ device.	eighteen minutes
oxygen saturation	Continuous quantitative variable, will be measured by "Welch Allyn" measuring instrument\ device. and presents the degree of oxygen concentration in the blood.	eighteen minutes

Collaborators and Investigators

• Sponsor: Pavel Goldstein

Study record dates

Study Major Dates

• Study Start (ACTUAL): January 1, 2022
• Primary Completion (ANTICIPATED): July 15, 2022
• Study Completion (ANTICIPATED): December 30, 2022

Study Registration Dates

• First Submitted: May 23, 2022
• First Submitted That Met QC Criteria: May 26, 2022
• First Posted (ACTUAL): May 27, 2022

Study Record Updates

• Last Update Posted (ACTUAL): May 27, 2022
• Last Update Submitted That Met QC Criteria: May 26, 2022
• Last Verified: May 1, 2022

More Information

Terms related to this study

• Other Study ID Numbers: Upshaifa

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No